TORONTO, ONTARIO / ACCESSWIRE / CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company") a global medical provider of electrocardiogram ("ECG") acquisition and management ...
NEW YORK--(BUSINESS WIRE)--AccurKardia, an ECG-led diagnostics software company, today announced a multi-year agreement with Lucem Health, a leading provider of clinical AI solutions. The partnership ...
Tempus AI (NasdaqGS:TEM) received FDA 510(k) clearance for Tempus ECG-PH, an AI-enabled tool that flags signs of pulmonary ...
Imperial College London researchers report detecting up to 81% of heart failure and 90% of valve disease cases from routine ...
The FDA has granted 510(k) clearance to Biofourmis’ RhythmAnalytics, a cloud-based software product that uses deep learning to read and interpret cardiac arrhythmias. According to a statement from the ...
With cases of arrhythmia and heart disease on the rise—thanks in large part to an aging global population—more tools and technologies are needed to speed up the process of diagnosing and beginning ...
・Roth Capital sees potential FDA clearance for the software. ・The FDA may want the company to use a different predicate device, pursue a different regulatory pathway, or provide additional data, the ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it ...
Apple’s latest smartwatch can now detect signs of a deadly heart condition – potentially saving lives across the UK. But Dr Helen Tyrer, a senior clinical research fellow at Imperial College London, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results